In this solo episode of unPAUSED, Dr. Mary Claire Haver explains why hair loss in women over 40 is a medical condition with real, identifiable causes rather than a cosmetic complaint to be dismissed as stress or aging. She starts with the biology of the hair growth cycle, describing the growth, transition, and resting phases and how normal daily shedding compares with the kind of hair loss that signals a problem. She also outlines the warning signs that require prompt evaluation by a dermatologist, including bald patches, a receding hairline, and scalp scarring, redness, scaling, or burning.
Dr. Haver walks through the most common types of hair loss in midlife women. She explains how androgenetic alopecia, also known as female pattern hair loss, often appears as a widening part and thinning at the crown while the hairline stays intact. She explains the hormonal mechanism behind it, including how the balance between estrogen and androgens like testosterone and dihydrotestosterone shifts as estrogen declines, leading to follicle miniaturization over time.
Next, she covers telogen effluvium, the dramatic shedding that can appear months after pregnancy, illness, surgery, significant stress, or rapid weight loss, including weight loss associated with GLP 1 medications. Dr. Haver explains why this type of shedding occurs, when it is likely to resolve, and how an underlying trigger that is not addressed can lead to ongoing hair loss.
A big focus of the episode is iron deficiency, one of the most frequently missed contributors to female hair loss. Dr. Haver explains why ferritin needs to be checked even when standard blood counts appear normal. She also covers thyroid dysfunction, low vitamin D, low vitamin B12, zinc imbalance, inadequate protein intake, and medications that may contribute to thinning hair. She details the lab work women should request and what to bring to a clinician appointment, including scalp photos, a medication and supplement list, and a record of nutrition and protein intake.
On treatment, Dr. Haver begins by addressing iron, thyroid, protein, and vitamin deficiencies. She then reviews topical and oral minoxidil, finasteride, spironolactone, platelet rich plasma, microneedling, low level laser therapy, and hair transplantation. She discusses whether hormone replacement therapy can treat hair loss, which supplements have supporting evidence, and why biotin is unlikely to help without a true deficiency. The episode closes with a practical plan for documenting hair loss, requesting the right tests, and addressing the underlying causes.
Guest Resources:
-
The Midlife Hair Loss Guide (The ‘Pause Life)
- Dr. Mary Claire (Substack)
-
The ‘Pause Life
- The 'Pause Wellness
-
Dr. Mary Claire Haver (Instagram)
-
Dr. Mary Claire Haver (YouTube)
- The Pause Life by Dr. Mary Claire Haver (Facebook)
Books:
-
“The New Menopause,” by Dr. Mary Claire Haver
- “The New Perimenopause: An Evidence-Based Guide to Surviving the Zone of Chaos and Feeling Like Yourself Again,” by Dr. Mary Claire Haver
Articles:
-
Hormonal Effects on Hair Follicles (International Journal of Molecular Sciences)
-
Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia (Tzu Chi Medical Journal)
-
Male and female pattern hair loss (Australian Prescriber)
-
Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis (Frontiers in Nutrition)
-
Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study (Obesity Pillars)
-
Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency (JAMA)
-
Risk of hair loss with different antidepressants: a comparative retrospective cohort study (International Clinical Psychopharmacology)
-
Alopecia associated with the use of selective serotonin reuptake inhibitors: Systematic review (Psychiatry Research)
-
Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature (Drugs - Real World Outcomes)
-
Abnormal Uterine Bleeding in Perimenopausal Women: The Role of Hysteroscopy and Its Impact on Quality of Life and Sexuality (Diagnostics)
-
Iron deficiency without anaemia: a diagnosis that matters (Clinical Medicine)
-
Association of serum 25-hydroxyvitamin D levels with all-cause and cause-specific mortality among postmenopausal females: results from NHANES (Journal of Translational Medicine)
-
Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials (BMJ)
-
A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women (Journal of the American Academy of Dermatology)
-
A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss (Journal of the American Academy of Dermatology)
-
Female-pattern hair loss: therapeutic update (Anais Brasileiros de Dermatologia)
-
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients (Journal of the American Academy of Dermatology)
-
No association between low-dose oral minoxidil and tachycardia in a large retrospective cohort study of patients with non-scarring alopecia (Journal of the American Academy of Dermatology)
-
No association between low-dose oral minoxidil and pericardial effusion in a large retrospective cohort study of nonscarring alopecia patients (Journal of the American Academy of Dermatology)
-
Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot study (International Journal of Women's Dermatology)
-
Bicalutamide 25 mg combined with minoxidil 1 mg versus minoxidil 1 mg for female pattern hair loss: A randomized double-blind clinical trial (JAAD International)
-
Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial (Frontiers in Medicine)
-
The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis (Cureus)
-
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia (Journal of the American Academy of Dermatology)
-
Finasteride 5 mg/day Treatment of Patterned Hair Loss in Normo-androgenetic Postmenopausal Women (International Journal of Trichology)
-
5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss (Journal of the European Academy of Dermatology and Venereology)
-
Efficacy of Finasteride in Female Pattern Hair Loss: A Meta-Analysis (Annals of Dermatology)
-
Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial (SKINmed)
- Menopause and Common Dermatoses: A Systematic Review (American Journal of Clinical Dermatology)
Other Resources:
-
General Information/The American Thyroid Association (ATA)
-
Vitamin B12 (NIH)
-
Zinc (NIH)
-
Propranolol Hydrochloride tablet (DailyMed/NIH)
-
Captopril Tablet (DailyMed/NIH)
-
Vitamin D (NIH)
-
Cronometer
-
Womens Rogaine Unscented- Minoxidil Aerosol, Foam (DailyMed/NIH)
-
Treatments for female pattern hair loss (Cochrane)
-
Minoxidil Tablet (DailyMed/NIH)
- Minoxidil: mechanisms of action on hair growth (British Journal of Dermatology)